Saturn_Healthcare_Ltd_31_Mar_2022_companies_house_set_of_accounts.html

Saturn_Healthcare_Ltd_31_Mar_2022_companies_house_set_of_accounts.html


1 April 2021 v2022.11.3 limited_company_frs_102_section_1a_v1_0_8 companies_houseSoftwarefalsetruetruetrueNo description of principal activitytruexbrli:purexbrli:sharesiso4217:GBP074943582021-04-012022-03-31074943582022-03-31074943582021-03-3107494358core:WithinOneYear2022-03-3107494358core:WithinOneYear2021-03-3107494358core:AfterOneYear2022-03-3107494358core:AfterOneYear2021-03-3107494358core:ShareCapital2022-03-3107494358core:ShareCapital2021-03-3107494358core:RetainedEarningsAccumulatedLosses2022-03-3107494358core:RetainedEarningsAccumulatedLosses2021-03-3107494358bus:Director12021-04-012022-03-3107494358bus:RegisteredOffice2021-04-012022-03-3107494358core:NetGoodwill2021-04-012022-03-3107494358core:Goodwill2021-04-012022-03-3107494358core:LandBuildings2021-04-012022-03-3107494358core:PlantMachinery2021-04-012022-03-3107494358core:MotorVehicles2021-04-012022-03-31074943582020-04-012021-03-3107494358core:NetGoodwill2022-03-3107494358core:NetGoodwill2021-04-0107494358core:NetGoodwill2021-03-3107494358core:LandBuildings2021-04-0107494358core:PlantMachinery2021-04-01074943582021-04-0107494358core:LandBuildings2022-03-3107494358core:PlantMachinery2022-03-3107494358core:LandBuildings2021-03-3107494358core:PlantMachinery2021-03-310749435812021-04-012022-03-3107494358countries:EnglandWales2021-04-012022-03-3107494358bus:AuditExemptWithAccountantsReport2021-04-012022-03-3107494358bus:PrivateLimitedCompanyLtd2021-04-012022-03-3107494358bus:SmallEntities2021-04-012022-03-3107494358bus:FullAccounts2021-04-012022-03-3107494358bus:Director22021-04-012022-03-31
Company registration number:
07494358
Saturn Healthcare Ltd
Unaudited Filleted Financial Statements for the year ended
31 March 2022
Saturn Healthcare Ltd
Chartered accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Saturn Healthcare Ltd
Year ended
31 March 2022
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the
financial statements
of
Saturn Healthcare Ltd
for the year ended
31 March 2022
which comprise the income statement, statement of income and retained earnings, statement of financial position and related notes from the company’s accounting records and from information and explanations you have given me.
As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), I am subject to its ethical and other professional requirements which are detailed at icaew.com/​regulations.
This report is made solely to the Board of Directors of
Saturn Healthcare Ltd
, as a body. My work has been undertaken solely to prepare for your approval the
financial statements
of
Saturn Healthcare Ltd
and state those matters that I have agreed to state to the Board of Directors of
Saturn Healthcare Ltd
, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than
Saturn Healthcare Ltd
and its Board of Directors, as a body, for my work or for this report.
It is your duty to ensure that
Saturn Healthcare Ltd
has kept adequate accounting records and to prepare statutory
financial statements
that give a true and fair view of the assets, liabilities, financial position and profit of
Saturn Healthcare Ltd
. You consider that
Saturn Healthcare Ltd
is exempt from the statutory audit requirement for the year.
I have not been instructed to carry out an audit or a review of the financial statements of Saturn Healthcare Ltd. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.
Saturn Accountancy Services Limited
Chartered Accountants
Old Farm, Marsh Lane
Burgh Castle
Great Yarmouth
Norfolk
NR31 9QH
United Kingdom
Date:
15 July 2022
Saturn Healthcare Ltd
Statement of Financial Position
31 March 2022
20222021
Note££
Fixed assets    
Intangible assets 5
117,266
 
181,125
 
Tangible assets 6
2,073,794
 
2,098,989
 
2,191,060
 
2,280,114
 
Current assets    
Debtors 7
1,708,536
 
1,590,062
 
Cash at bank and in hand
327,599
 
169,030
 
2,036,135
 
1,759,092
 
Creditors: amounts falling due within one year 8
(451,262
)
(496,923
)
Net current assets
1,584,873
 
1,262,169
 
Total assets less current liabilities 3,775,933   3,542,283  
Creditors: amounts falling due after more than one year 9
(2,426,673
)
(2,600,945
)
Provisions for liabilities
(85,081
)
(91,703
)
Net assets
1,264,179
 
849,635
 
Capital and reserves    
Called up share capital
1
 
1
 
Profit and loss account
1,264,178
 
849,634
 
Shareholders funds
1,264,179
 
849,635
 
For the year ending
31 March 2022
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
15 July 2022
, and are signed on behalf of the board by:
K Buckworth
Director
Company registration number:
07494358
Saturn Healthcare Ltd
Notes to the Financial Statements
Year ended
31 March 2022

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
Old Farm, Marsh Lane
,
Burgh Castle
,
Great Yarmouth
,
Norfolk
,
NR31 9QH
, England.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Goodwill

Purchased goodwill arises on business acquisitions and represents the difference between the cost of acquisition and the fair values of the identifiable assets and liabilities acquired.
Goodwill is initially recorded at cost, and is subsequently stated at cost less any accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over the useful economic life of the asset. Where a reliable estimate of the useful life of goodwill cannot be made, the life is presumed not to exceed five years.

Intangible assets

Intangible assets are initially measured at cost and are subsequently measured at cost less any accumulated amortisation and accumulated impairment losses or at a revalued amount. However, Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Any intangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Goodwill
10% straight line

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Land and buildings
Straight line over 50 years
Plant and machinery
25% and 15% straight line
Motor vehicles
25% straight line

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is more likely than not that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured on an undiscounted basis at the tax rates that would apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted at the statement of financial position date.

Provisions for liabilities

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

4 Average number of employees

The average number of persons employed by the company during the year was
67
(2021:
60.00
).

5 Intangible assets

Goodwill
£
Cost  
At
1 April 2021
and
31 March 2022
638,587
 
Amortisation  
At
1 April 2021
457,462
 
Charge
63,859
 
At
31 March 2022
521,321
 
Carrying amount  
At
31 March 2022
117,266
 
At 31 March 2021
181,125
 

6 Tangible assets

Land and buildingsPlant and machinery etc.Total
£££
Cost      
At
1 April 2021
1,977,244
 
402,914
 
2,380,158
 
Additions -  
76,712
 
76,712
 
At
31 March 2022
1,977,244
 
479,626
 
2,456,870
 
Depreciation      
At
1 April 2021
142,102
 
139,067
 
281,169
 
Charge
37,545
 
64,362
 
101,907
 
At
31 March 2022
179,647
 
203,429
 
383,076
 
Carrying amount      
At
31 March 2022
1,797,597
 
276,197
 
2,073,794
 
At 31 March 2021
1,835,142
 
263,847
 
2,098,989
 

7 Debtors

20222021
££
Trade debtors
37,729
 
9,457
 
Amounts owed by group undertakings and undertakings in which the company has a participating interest
1,649,557
 
1,535,392
 
Other debtors
21,250
 
45,213
 
1,708,536
 
1,590,062
 

8 Creditors: amounts falling due within one year

20222021
££
Bank loans and overdrafts
175,293
 
221,266
 
Trade creditors
5,078
 
12,396
 
Amounts owed to group undertakings and undertakings in which the company has a participating interest
1,885
  -  
Taxation and social security
188,747
 
174,836
 
Other creditors
80,259
 
88,425
 
451,262
 
496,923
 

9 Creditors: amounts falling due after more than one year

20222021
££
Bank loans and overdrafts
2,426,673
 
2,600,945
 
The bank loan is secured by a legal charge on the freehold property and a Debenture for the benefit of Barclays Bank PLC. There is also a personal guarantee in place for £150,000 from Mr Darren Buckworth and Mr Kelly Buckworth.
Included within creditors: amounts falling due after more than one year is an amount of £1,682,462 (2021: £1,878,256) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.

11 Controlling party

Saturn Healthcare Ltd is the 100% wholly owned subsidary of Saturn Healthcare (Holdings) Ltd. Saturn Healthcare (Holdings) Ltd is owned 100% by Buckworth Investments 2 Ltd and Buckworth Investments 2 Ltd is 100% jointly owned by the directors of this company.